Australian Clinical Labs Limited
ASX ACL.AX
Australian Clinical Labs Limited Dividends Paid for the year ending June 30, 2024: USD -13.30 M
-
Australian Clinical Labs Limited Dividends Paid for the year ending June 30, 2023 was USD -64.47 M, a -285.76% change year over year.
-
Australian Clinical Labs Limited Dividends Paid for the year ending June 30, 2022 was USD -16.71 M, a 46.93% change year over year.
-
Australian Clinical Labs Limited Dividends Paid for the year ending June 30, 2021 was USD -31.49 M, a 0.00% change year over year.
-
Australian Clinical Labs Limited Dividends Paid for the year ending June 30, 2020 was USD 0.00, a 0.00% change year over year.
| Date | Dividends Paid | Capital Expenditure | Other Financing Activities | Net Cash Used Provided By Financing Activities |
|---|
| CEO | Ms. Melinda McGrath |
| IPO Date | May 14, 2021 |
| Location | Australia |
| Headquarters | 1868-1892 Dandenong Road |
| Employees | 4,900 |
| Sector | Health Care |
| Industries | |
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Past 5 years
USD 0.87
StockViz Staff
January 15, 2025
Any question? Send us an email